Arin戰術極端風險主動型ETF ATTR 深 滬
已收盤 08-07 16:00:00 美东时间
95.2816
+0.089
+0.09%
華盛通- 最 高95.2816
- 今 開95.27
- 成交量 285股
- 最 低 95.27
- 昨 收 95.1925
- 總市值 9424.30万
- 52周最高 95.2816
- 市盈率 靜 --
- 換手率 0.03%
- 52周最低 88.71
- 委 比 2.83%
- 總股本 98.91万
- 歷史最高 95.2816
- 量 比 0.02
- 振 幅 0.01%
- 歷史最低 88.71
- 每 手 1
- 風險率 1.68%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Intellia upgraded at Evercore ISI on nex-z hypothesis
Shares of Intellia Therapeutics (NTLA) traded higher in the premarket on Friday after Evercore ISI upgraded the gene-editing biotech to Outperform from Inline, citing the company’s latest findings on ...
08-07 20:30
Microsoft, Amazon among Nasdaq's weekly gainers after bumper earnings
The Nasdaq Composite Index (COMP:IND) closed 1% higher on Friday, led by gains in Amazon (AMZN) after the e-commerce giant reported strong quarterly results. On Thursday, the index closed 2.78% higher...
08-01 04:22
Alnylam drops after guidance cut on ATTR-CM headwinds
Alnylam Pharmaceuticals (ALNY) lost more than 25% to reach a new 52-week low on Thursday after the company, with its Q2 2026 results, lowered its full-year outlook for product revenues, citing headwin...
07-30 22:36
Ionis extends losses as Roche scraps two partnered studies
Shares of Ionis Pharmaceuticals (IONS) continued to trade lower on Friday after Roche (RHHBY) (RHHBF) said it is discontinuing clinical studies for two experimental therapies developed with the U.S. d...
07-10 22:21
Biggest stock movers Thursday: AZN, BBIO, RXT, and more
Stock futures edged up on Thursday as markets showed resilience despite a spike in energy prices following President Donald Trump's declaration that the brief ceasefire with Iran is “over.” Here are s...
07-09 22:05
美股前瞻 | 海力士IPO点燃AI热情！存储、光通信齐涨，康宁涨逾6%，美光涨逾5%；Meta自研AI芯片计划9月量产；美银喊话英伟达：“绝佳买入机会”
海力士IPO点燃AI热情！存储、光通信齐涨，康宁涨逾6%，美光涨逾5%；2027算力翻倍！Meta自研AI芯片计划9月量产；美银喊话英伟达：“绝佳买入机会”>>
07-09 20:10
联合开发心脏药物III期试验未达主要终点 阿斯利康(AZN.US)与Ionis(IONS.US)股价暴跌
阿斯利康（AZN.US）与Ionis（IONS.US）联合开发的一款实验性心脏病药物在后期临床试验中未能达到主要疗效终点，该股伦敦挂牌股价周三暴跌近10%
07-09 19:29
Pfizer, Alnylam, BridgeBio gain after late-stage trial setback for Astra/ Ionis
Pfizer (PFE), Alnylam Pharma (ALNY), and BridgeBio Pharma (BBIO), which market drugs for a rare heart condition known as ATTR-CM, are on the rise in the premarket on Thursday after AstraZeneca (AZN) a...
07-09 19:26
